Kamada (Kamada) Price-to-Operating-Cash-Flow

: 71.83 (As of Today)

View and export this data going back to 2013. Start your Free Trial

As of today (2024-04-19), Kamada's share price is $5.10. Kamada's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.07. Hence, Kamada's Price-to-Operating-Cash-Flow Ratio for today is 71.83.

The historical rank and industry rank for Kamada's Price-to-Operating-Cash-Flow or its related term are showing as below:

KMDA' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.46 Med: 21.62 Max: 147.94
Current: 70.07

During the past 13 years, Kamada's highest Price-to-Operating-Cash-Flow Ratio was 147.94. The lowest was 6.46. And the median was 21.62.

KMDA's Price-to-Operating-Cash-Flow is ranked worse than
91.86% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.36 vs KMDA: 70.07

Kamada's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.08. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.07.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Kamada was -87.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -42.70% per year.

During the past 13 years, Kamada's highest 3-Year average Operating Cash Flow per Share Growth Rate was 135.30% per year. The lowest was -42.70% per year. And the median was 7.95% per year.

Kamada Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Kamada's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kamada Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

9.23

12.76

5.70

73.26

Kamada Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow																5.70	10.09	22.27	40.08	73.26

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kamada's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kamada Price-to-Operating-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Kamada's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Kamada's Price-to-Operating-Cash-Flow falls into.

Kamada Price-to-Operating-Cash-Flow Calculation

Kamada's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	5.10	/	0.071
	=	71.83

Kamada's Share Price of today is $5.10.
Kamada's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.07.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Kamada Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Kamada's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Kamada (Kamada) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kamada Ltd (NAS:KMDA) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

KMDA:Israel

Address

2 Holzman Street, P.O. Box 4081, Science Park, Rehovot, ISR, 7670402

Website

https://www.kamada.com

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.